The Role of MicroRNAs in Chronic Myeloid Leukemia (CML) Treatment, Biomarkers, and Resistance to Tyrosine Kinase Inhibitor: A Bioinformatics-Based Analysis
Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by the reciprocal translocation of the BCR-ABL1 oncogene, which activates tyrosine kinase resulting in uncontrolled cell proliferation and apoptosis suppression. Although Imatinib (IM) is an effective treatment, IM resistance rem...
Published in: | Journal of Tropical Life Science |
---|---|
Main Author: | Mohamad S.F.S.; Ramlee R.A.; Elias M.H. |
Format: | Article |
Language: | English |
Published: |
Brawijaya University
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85212240293&doi=10.11594%2fjtls.14.03.18&partnerID=40&md5=213b71b6ae9637915dcdfc0c2fe20c3e |
Similar Items
-
Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
by: Abu Seman, et al.
Published: (2024) -
Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
by: Seman Z.A.; Ahid F.; Kamaluddin N.R.; Sahid E.N.M.; Esa E.; Said S.S.M.; Azman N.; Mat W.K.D.W.; Abdullah J.; Ali N.A.; Khalid M.K.N.M.; Yusoff Y.M.
Published: (2024) -
Identification of MicroRNAs Binding Site in the 3’Untranslated Region of Long Non-Coding RNA, MIR497HG: A Bioinformatic Prediction
by: Shamsuddin N.; Hatta F.H.M.; Hasan M.H.; Noorden M.S.A.
Published: (2024) -
CNN-Based Classification of Acute Myeloid Leukemia Blood Samples
by: Ahmad A.R.; Zainudin N.A.; Radzi M.D.I.M.; Halim N.H.A.; Osman M.K.; Saad Z.
Published: (2024) -
Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia
by: Mat Yusoff Y.; Ahid F.; Abu Seman Z.; Abdullah J.; Kamaluddin N.R.; Esa E.; Zakaria Z.
Published: (2021)